Joseph M Leone

CIK 1176381 · Vice Chairman and CFO · last filed 2017-07-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

Companies

Total Filings

Lifetime Open-Market Net

-$9.49M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

CIT price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest

OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Related Filers

CIT GROUP INC — 43 joint filings, latest 2010-04-29

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
Alliqua BioMedical, Inc. (ALQA) Delisted	Director	7,304	—	—	$19.7K	6	2017-07-05
CIT GROUP INC (CIT) Delisted	Vice Chairman and CFO	3,380	$53.50	$180.9K	-$9.51M	22	2010-04-29

Recent Filings · Page 4 of 4

35 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2007-02-06	CIT GROUP INC (CIT) Delisted	Mixed	+24,142	-$1.26M	EDGAR
2007-02-05	CIT GROUP INC (CIT) Delisted	Sell (S)	−12,930	-$759.9K	EDGAR
2007-02-05	CIT GROUP INC (CIT) Delisted	Mixed	+54,330	$727.0K	EDGAR
2007-02-05	CIT GROUP INC (CIT) Delisted	Sell (S)	−41,400	-$2.43M	EDGAR
2007-01-19	CIT GROUP INC (CIT) Delisted	Grant (A)	—	$0	EDGAR

Showing 31–35 of 35

Prev Page 4 of 4

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.